Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer
Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer
Recruiting · NCT07506876 · Registry updated 2026-05-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer | Breast Cancer - Infiltrating Ductal Carcinoma; HER-2 Positive Breast Cancer | Recruiting | Phase 2 | 2026-05-01 | NCT07506876 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Legacy Health System | 3 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Legacy Good Samaritan Medical Center | Portland | United States | 5 |
| Legacy Meridian Park Medical Center | Tualatin | United States | 2 |
| Legacy Mount Hood Medical Center | Gresham | United States | 64 |
| Legacy Salmon Creek Medical Center | Vancouver | United States | 3 |